SCHEMBL28721663

SCHEMBL28721663

CCOc1cc(I)c(C(=O)O)cc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
GAA P10253 1/20 0.45
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
POLB P06746 2/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
TP53 P04637 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28720949 0.86 TSHR (0.68) TSHRHSD17B10GAAMAPTSMN1; SMN2
SCHEMBL1645081 0.85 TSHR (0.53) TSHRHSD17B10GAAMAPTSMN1; SMN2
SCHEMBL11577236 0.83 MAPT (0.44) TSHRHSD17B10GAAMAPTSMN1; SMN2
SCHEMBL28406321 0.81 TSHR (0.49) TSHRHSD17B10GAAMAPTSMN1; SMN2
SCHEMBL3542556 0.80 TSHR (0.48) TSHRHSD17B10GAAMAPTSMN1; SMN2
SCHEMBL9721688 0.80 MAPT (0.55) TSHRHSD17B10MAPTSMN1; SMN2POLB
SCHEMBL13948927 0.79 TSHR (0.57) TSHRHSD17B10GAAMAPTPOLB
SCHEMBL3266479 0.79 SMN1; SMN2 (0.60) GAAMAPTSMN1; SMN2AKR1C3AKR1C2
SCHEMBL8901736 0.78 AKR1C3 (0.51) GAAMAPTSMN1; SMN2AKR1C3AKR1C2
SCHEMBL30309542 0.77 TSHR (0.48) TSHRHSD17B10GAAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110845409-B Method for synthesizing neratinib intermediate 江苏慧聚药业股份有限公司 2022-04-12 CN disclosed
CN-110845409-A Method for synthesizing neratinib intermediate 海门慧聚药业有限公司 2020-02-28 CN disclosed